Transradial access site in percutaneous coronary intervention for ST elevation myocardial infarction was associated with a significant reduction in mortality, major adverse cardiac events and major access site complications. The authors acknowledged that the absence of sufficiently large trials precluded any definitive conclusion. Despite imperfections in the conduct of the review, the conclusions are likely to be reliable.
largest study in the meta-analysis showed a difference in favour of the radial group which was not statistically significant.
There was a significant difference in major adverse cardiac events which favoured the radial group (OR 0.62; 95% CI 0.43 to 0.90; nine trials). The odds of a major bleeding event were lower for the radial group (OR 0.63; 95% CI 0.35 to 1.12; eight trials) but this difference was not statistically significant. Significantly less access site complications were observed in the radial group (OR 0.30; 95% CI 0.19 to 0.48; five trials).
There was no evidence of heterogeneity (Ι²=0%) for the analyses on mortality, major adverse cardiac events and major bleeding outcomes. No evidence of publication bias was found.
Authors' conclusions
This review demonstrated that transradial access site in ST elevation myocardial infarction was associated with a significant reduction in mortality, major adverse cardiac events and major access site complications, and supported the use of radial access over the transfemoral route for ST elevation myocardial infarction PCI.
CRD commentary
The review question and selection criteria were clear. Several bibliographic sources were searched. It was unclear whether study selection and data extraction were carried out with sufficient attempts to minimise error and bias.
Study details and outcome definitions were reported. All included studies were randomised controlled trials. All except one were small and may have been insufficiently powered to detect a significant effect. The authors did not state that they assessed study validity so the reliability of trials was unclear.
Methods of analysis appeared appropriate. There was no evidence of statistical heterogeneity, and the trial results appeared relatively consistent.
The conclusions reflected the evidence. The authors acknowledged these were not definitive due to the absence of adequately powered trials. Despite imperfections in the conduct of the review, the conclusions are likely to be reliable.
Implications of the review for practice and research
Practice: The authors did not state any implications for practice.
Research: The authors stated that an adequately powered RCT that compared the influence of arterial access site selection on clinical outcomes in primary PCI patients was needed.
Funding
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